Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke
- 8 November 2011
- journal article
- Published by Springer Science and Business Media LLC in Indian Journal of Clinical Biochemistry
- Vol. 27 (2), 186-190
- https://doi.org/10.1007/s12291-011-0172-9
Abstract
Stroke is the third major cause of death and foremost cause of disability worldwide. Cerebrovascular stroke remains largely a clinical diagnosis. The use of biomarkers in diagnosing stroke and assessing prognosis is an emerging and rapidly evolving field. The study aimed to investigate the predictive value of neurobiochemical marker of brain damage (neuron-specific enolase [NSE]) with respect to degree of disability at the time of admission and neurological worsening in acute ischemic stroke patients. We investigated 150 patients with cerebrovascular stroke who were admitted within 72 h of onset of stroke in the Department of Neurology at SAIMS. Venous blood samples were taken after admission and NSE was analyzed by solid enzyme linked immunosorbent assay using Analyzer and microplate reader from Biored: Code 680. In all patients, the neurological status was evaluated by a standardized neurological examination and the National Institutes of Health Stroke Scale on admission and on day 7. Serum NSE concentration was found to significantly correlate with both degree of disability and neurological worsening in acute ischemic stroke cases in the present study. The maximum serum NSE level within 72 h of admission was significantly higher in patients with greater degree of disability at the time of admission. Serum NSE levels were also found to be significantly elevated in patients with bad neurological outcome. Our study showed that serum NSE has high predictive value for determining severity and early neurobehavioral outcome after acute stroke.Keywords
This publication has 19 references indexed in Scilit:
- Early neurological deterioration in acute stroke: clinical characteristics and impact on outcomeQJM: An International Journal of Medicine, 2006
- Cerebrospinal fluid and serum neuron‐specific enolase concentrations in a normal population*European Journal of Neurology, 2005
- Neurone‐specific enolase and N‐acetyl‐aspartate as potential peripheral markers of ischaemic strokeEuropean Journal of Clinical Investigation, 1999
- Serum Neuron-Specific Enolase, Carnosinase, and Their Ratio in Acute StrokeStroke, 1996
- Serum neurone‐specific enolase as an indicator of stroke volumeEuropean Journal of Clinical Investigation, 1996
- Neuron-Specific Enolase in Gerbil Brain and Serum After Transient Cerebral IschemiaStroke, 1995
- Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases.Stroke, 1994
- Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemiaBrain Research, 1993
- S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damageJournal of Neurosurgery, 1989
- Neuron Specific Enolase, A Clinically Useful Marker for Neurons and Neuroendocrine CellsAnnual Review of Neuroscience, 1987